Rare disease medicine approvals

STO-REC-STAT1YQ3S0T1 Official
55

China · 2024

Rare disease medicine approvals in China stood at 55 in 2024 (NMPA).

Original source
Publisher
NMPA
Authority tier
T1 Official
Locator
China approves 48 innovative drugs in 2024
Retrieved
17 Sep 2026
Status
Verified

What the source says

In addition, the nation also approved 55 rare disease medicines and 106 pediatric medicines.

Verbatim extraction verified: The figure 55 is directly attested in the quoted passage (China approves 48 innovative drugs in 2024).

The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.

Cite this figure

Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.

APA
National Medical Products Administration. (2024). China approves 48 innovative drugs in 2024. Retrieved September 17, 2026, from https://english.nmpa.gov.cn/2025-03/19/c_1079532.htm. Via StatOrigin, https://statorigin.org/stat/stat_1YQ3S0N101YBKZ8R9REBD05AKY
MLA
National Medical Products Administration. "China approves 48 innovative drugs in 2024." 2024, https://english.nmpa.gov.cn/2025-03/19/c_1079532.htm. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_1YQ3S0N101YBKZ8R9REBD05AKY.
Chicago
National Medical Products Administration. "China approves 48 innovative drugs in 2024." 2024. https://english.nmpa.gov.cn/2025-03/19/c_1079532.htm. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_1YQ3S0N101YBKZ8R9REBD05AKY.
BibTeX
@misc{nmpa2024rared05aky, author = {{National Medical Products Administration}}, title = {China approves 48 innovative drugs in 2024}, year = {2024}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_1YQ3S0N101YBKZ8R9REBD05AKY}, note = {Original source: https://english.nmpa.gov.cn/2025-03/19/c\_1079532.htm. Accessed September 17, 2026.} }

Provenance and verification

Everything needed to check this number yourself, without taking our word for it.

Chain of Custody · Verification Audit
Record: STO-REC-STAT1YQ3S0 T1 Official

Primary Source

Publisher
National Medical Products Administration · homepage ↗
Authority tier
Tier 1 · Multilateral Official
Report
China approves 48 innovative drugs in 2024
Type
Press release
Published
Locator
China approves 48 innovative drugs in 2024
Retrieved
17 September 2026
Link status
Reachable (HTTP 200)
Report licence
See source

Verification & Integrity

Audit status
Verified
Review protocol
Editorial review
Checked on
17 September 2026
Last revision
17 September 2026
Archival URI
/stat/stat_1YQ3S0N101YBKZ8R9REBD05AKY